(Q50303233)

2 March 2018

title

Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series. (English)

1 reference

2 March 2018

disability affecting intellectual abilities

1 reference

intellectual disability

1 reference

based on heuristic

inferred from title

1 reference

Manan Shastri

1

1 reference

2 March 2018

Lakshmiramana Alla

series ordinal

2

1 reference

2 March 2018

Manga Sabaratnam

series ordinal

3

1 reference

2 March 2018

language of work or name

English

0 references

publication date

4 August 2006

1 reference

2 March 2018

Journal of Psychopharmacology

published in

1 reference

2 March 2018

volume

20

1 reference

2 March 2018

issue

6

1 reference

2 March 2018

page(s)

863-867

1 reference

2 March 2018

Psychiatric disorders in the mentally retarded: types, problems, and challenges

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: epidemiological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

Psychosis in Mental Handicap. The tenth Blake Marsh lecture delivered before the Royal College of Psychiatrists, February 2, 1976.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

The prevalence of psychiatric morbidity in mentally retarded adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

Case series: use of ziprasidone for maladaptive symptoms in youths with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

The motor disorders of mental handicap. An overlap with the motor disorders of severe psychiatric illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

Aripiprazole in an adult with Asperger disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

Aripiprazole for maladaptive behavior in pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106067765

21 January 2018

Identifiers

DOI

10.1177/0269881106067765

1 reference

2 March 2018

1 reference

2 March 2018